These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 11558828
1. Renal effects of adenosine A1-receptor antagonists in congestive heart failure. Gottlieb SS. Drugs; 2001; 61(10):1387-93. PubMed ID: 11558828 [Abstract] [Full Text] [Related]
2. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. Gottlieb SS, Skettino SL, Wolff A, Beckman E, Fisher ML, Freudenberger R, Gladwell T, Marshall J, Cines M, Bennett D, Liittschwager EB. J Am Coll Cardiol; 2000 Jan; 35(1):56-9. PubMed ID: 10636259 [Abstract] [Full Text] [Related]
3. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, Beckman E, Abraham WT. Circulation; 2002 Mar 19; 105(11):1348-53. PubMed ID: 11901047 [Abstract] [Full Text] [Related]
4. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure. Mitrovic V, Seferovic P, Dodic S, Krotin M, Neskovic A, Dickstein K, de Voogd H, Böcker C, Ziegler D, Godes M, Nakov R, Essers H, Verboom C, Hocher B. Circ Heart Fail; 2009 Nov 19; 2(6):523-31. PubMed ID: 19919976 [Abstract] [Full Text] [Related]
9. Effects of adenosine receptor subtype A1 on ventricular and renal function. Lucas DG, Patterson T, Hendrick JW, Holder J, Sample JA, Joffs C, Davis J, Goldberg A, Mukherjee R, Smits GJ, Spinale FG. J Cardiovasc Pharmacol; 2001 Oct 19; 38(4):618-24. PubMed ID: 11588532 [Abstract] [Full Text] [Related]
10. Adenosine A2 receptor-mediated regulation of renal hemodynamics and glomerular filtration rate is abolished in diabetes. Persson P, Hansell P, Palm F. Adv Exp Med Biol; 2013 Oct 19; 765():225-230. PubMed ID: 22879037 [Abstract] [Full Text] [Related]
11. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats. Schnackenberg CG, Merz E, Brooks DP. Br J Pharmacol; 2003 Aug 19; 139(8):1383-8. PubMed ID: 12922924 [Abstract] [Full Text] [Related]
12. The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment. Dittrich HC, Gupta DK, Hack TC, Dowling T, Callahan J, Thomson S. J Card Fail; 2007 Oct 19; 13(8):609-17. PubMed ID: 17923351 [Abstract] [Full Text] [Related]
15. Effects of selective A1 receptor blockade on glomerular hemodynamics: involvement of renin-angiotensin system. Munger KA, Jackson EK. Am J Physiol; 1994 Nov 19; 267(5 Pt 2):F783-90. PubMed ID: 7977781 [Abstract] [Full Text] [Related]
17. Adenosine A1 receptor antagonist blunts urinary potassium excretion, but not renal hemodynamic effects, induced by carbonic anhydrase inhibitor in rats. Zhou X, Kost CK. J Pharmacol Exp Ther; 2006 Feb 19; 316(2):530-8. PubMed ID: 16278313 [Abstract] [Full Text] [Related]
18. Renal adenosine A3 receptors in the rat: assessment of functional role. Mozaffari MS, Abebe W, Warren BK. Can J Physiol Pharmacol; 2000 May 19; 78(5):428-32. PubMed ID: 10841439 [Abstract] [Full Text] [Related]
19. The effects of adenosine on water and sodium excretion. Yagil Y. J Pharmacol Exp Ther; 1994 Feb 19; 268(2):826-35. PubMed ID: 8113995 [Abstract] [Full Text] [Related]